The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Total operating expenses of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars)
Total operating expenses of GW Pharmaceuticals 2017-2020
In 2020, GW Pharmaceuticals spent nearly 580 million U.S. dollars on total operating expenses, which is a significant increase from around 175 million U.S. dollars spent in 2017. This statistic illustrates the total operating expenses of GW Pharmaceuticals worldwide from 2017 to 2020. In May 2021, the company was acquired by Ireland-based biopharma company Jazz Pharmaceuticals.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Net loss of GW Pharmaceuticals from 2017 to 2020
- Premium Statistic Total revenue of GW Pharmaceuticals 2017-2020
- Basic Statistic Jazz Pharmaceuticals R&D expenditure 2016-2024
- Basic Statistic Number of employees at GW Pharmaceuticals 2020, by geography
- Basic Statistic Total assets of Jazz Pharmaceuticals 2016-2024
- Premium Statistic Total revenue of Jazz Pharmaceuticals 2016-2024
- Premium Statistic Largest M&A deals in cannabis industry in North America 2021
- Basic Statistic Employees at Jazz Pharmaceuticals 2021-2024, by region
- Basic Statistic Medical cannabis patients Canada 2023-2027
- Premium Statistic Medical cannabis market size in the United States 2023-2027
About the region
10
- Premium Statistic Jazz Pharmaceuticals top products sales 2022-2024
- Premium Statistic Sales forecast of major cannabis pharmaceutical products by world region 2023-2027
- Premium Statistic Sales forecast of major cannabis pharmaceutical products worldwide 2023-2027
- Premium Statistic Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Basic Statistic Cannabis patents under Jazz Pharmaceuticals by patent family 2023
- Basic Statistic Share of cannabis clinical trials worldwide by sponsor 2010-2023
- Premium Statistic Cannabis patents under Jazz Pharmaceuticals' subsidiaries 2023
- Basic Statistic Medicine spending in emerging pharmaceutical markets 2026
- Basic Statistic 3 year average R&D cost to develop new biopharmaceutical compounds 2010-2020
- Premium Statistic World pharmaceutical market CAGR forecast by region group 2024-2028
Selected statistics
10
- Basic Statistic Medical cannabis patients Denmark 2023-2027
- Premium Statistic Leading therapy classes by spending global market 2028
- Premium Statistic Projected medical cannabis market size in Europe by country 2027
- Premium Statistic Bristol-Myers Squibb's ad and promo spending 2011-2024
- Premium Statistic Medical cannabis market value in Italy 2020-2030, by segment
- Basic Statistic Market share of the leading global pharmaceutical markets 2024
- Basic Statistic Country comparison in spending on medicine 2026
- Premium Statistic R&D spending growth worldwide on pharmaceuticals 2019-2032
- Basic Statistic Spending and growth worldwide in oncology market 2025-2029
- Premium Statistic Pharmaceutical market size worldwide 2001-2029
Other regions
10
- Premium Statistic Distribution of medical cannabis oil exports Canada 2020, by importer
- Premium Statistic Medical cannabis market size forecast by U.S. state 2027
- Premium Statistic Medical cannabis market size in Europe by country 2023
- Basic Statistic Share of population using MMJ in fastest growing U.S. markets in 2019
- Basic Statistic Top growing U.S. medical marijuana markets by daily patient growth 2019
- Basic Statistic Gen-Z share of cannabis sales in U.S. states by quarter 2020-2021
- Premium Statistic Market value of CBD in Latin America 2023, by country
- Premium Statistic Market value of CBD in Ecuador 2023-2027
- Premium Statistic Market value of CBD in Peru 2023-2027
- Premium Statistic Market value of CBD in Chile 2023-2027
Related statistics
10
- Premium Statistic Opinion on drug spending reduction due to biosimilars for specialty drugs 2017-2020
- Basic Statistic Quarterly medical cannabis oil products sold in Canada 2016-2019
- Basic Statistic CBD market size distributed by pharmacies and practitioners in the U.S. 2019-2026
- Basic Statistic Spending on direct-to-consumer drug advertising in the U.S. 2016-2018, by media type
- Basic Statistic CBD pharmaceuticals market size in the United States 2019-2026
- Basic Statistic Medical cannabis market size in the United States by type 2019 and 2025
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Basic Statistic R&D cost to develop new pharmaceutical compounds 2010-2020
- Premium Statistic Biosimilars approved for marketing Europe vs U.S. 2022 by year since approval
- Basic Statistic Popular methods of cannabinoid synthesis worldwide 2021
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
GW Pharmaceuticals. (February 26, 2021). Total operating expenses of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/1264939/operating-expenses-of-gw-pharmaceuticals/
GW Pharmaceuticals. "Total operating expenses of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) ." Chart. February 26, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/1264939/operating-expenses-of-gw-pharmaceuticals/
GW Pharmaceuticals. (2021). Total operating expenses of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/1264939/operating-expenses-of-gw-pharmaceuticals/
GW Pharmaceuticals. "Total Operating Expenses of Gw Pharmaceuticals from 2017 to 2020 (in Million U.S. Dollars) ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Feb 2021, /statistics/1264939/operating-expenses-of-gw-pharmaceuticals/
GW Pharmaceuticals, Total operating expenses of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1264939/operating-expenses-of-gw-pharmaceuticals/ (last visited July 25, 2026)
Total operating expenses of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) [Graph], GW Pharmaceuticals, February 26, 2021. [Online]. Available: /statistics/1264939/operating-expenses-of-gw-pharmaceuticals/
Advertisement